$4.245
-0.235[-5.25%]
At close: Apr 24
$4.53
0.2850[6.71%]
After Hours: 6:01PM EDT
Autolus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Autolus Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/14/2024 | AM | AUTL | Q1 | -$0.23 | -$0.24 | — | — | $1.29M | $670.00K | — | — | Get Alert |
03/14/2024 | AM | AUTL | Q4 | -$0.23 | -$0.25 | -$0.45 | -80.00% | $3.83M | — | $0.00 | — | Get Alert |
11/02/2023 | AM | AUTL | Q3 | -$0.47 | -$0.25 | -$0.26 | -4.00% | $2.37M | $450.00K | $406.00K | -9.78% | Get Alert |
08/03/2023 | AM | AUTL | Q2 | -$0.46 | -$0.22 | -$0.26 | -18.18% | $0.00 | $140.00K | $0.00 | -100.00% | Get Alert |
05/04/2023 | AM | AUTL | Q1 | -$0.41 | -$0.27 | -$0.23 | 14.81% | $166.00K | $350.00K | $1.29M | 269.14% | Get Alert |
03/07/2023 | AM | AUTL | Q4 | -$0.51 | -$0.27 | -$0.23 | 14.81% | $180.00K | $3.20M | $3.83M | 19.53% | Get Alert |
11/03/2022 | AM | AUTL | Q3 | -$0.47 | — | -$0.47 | — | $236.00K | — | $2.37M | — | Get Alert |
08/04/2022 | AM | AUTL | Q2 | -$0.47 | -$0.42 | -$0.46 | -9.52% | $1.65M | — | $0.00 | — | Get Alert |
05/05/2022 | AM | AUTL | Q1 | -$0.53 | — | -$0.41 | — | $269.00K | — | $166.00K | — | Get Alert |
03/10/2022 | AM | AUTL | Q4 | -$0.83 | -$0.51 | -$0.51 | 0.00% | $404.00K | $250.00K | $180.00K | -28.00% | Get Alert |
11/03/2021 | AM | AUTL | Q3 | -$0.72 | -$0.51 | -$0.47 | 7.84% | $680.00K | $250.00K | $236.00K | -5.60% | Get Alert |
08/05/2021 | AM | AUTL | Q2 | -$0.62 | -$0.50 | -$0.47 | 6.00% | $293.00K | $190.00K | $1.65M | 765.79% | Get Alert |
05/06/2021 | AM | AUTL | Q1 | -$0.60 | -$0.60 | -$0.53 | 11.67% | $338.00K | $340.00K | $269.00K | -20.88% | Get Alert |
03/04/2021 | AM | AUTL | Q4 | — | — | -$0.83 | — | $309.00K | $340.00K | $404.00K | 18.82% | Get Alert |
11/05/2020 | AM | AUTL | Q3 | -$0.61 | -$0.71 | -$0.72 | -1.41% | $297.00K | $300.00K | $680.00K | 126.67% | Get Alert |
08/06/2020 | AM | AUTL | Q2 | -$0.65 | -$0.71 | -$0.62 | 12.68% | $338.00K | $440.00K | $293.00K | -33.41% | Get Alert |
05/07/2020 | AM | AUTL | Q1 | -$0.69 | -$0.74 | -$0.60 | 18.92% | $1.96M | $600.00K | $338.00K | -43.67% | Get Alert |
03/03/2020 | AM | AUTL | Q4 | -$0.52 | -$0.74 | -$0.93 | -25.68% | $296.00K | $520.00K | $309.00K | -40.58% | Get Alert |
11/07/2019 | AM | AUTL | Q3 | -$0.69 | -$0.84 | -$0.61 | 27.38% | $1.96M | $580.00K | $297.00K | -48.79% | Get Alert |
Autolus Therapeutics (AUTL) is scheduled to report earnings on May 14, 2024. The last reported earnings were for reported on March 14, 2024 for Q4.
The Actual EPS was $-0.45, which missed the estimate of $-0.25.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.